Conference Day Two | Friday October 11, 2024
8:15 am Registration
Spotlighting the Intersection of Sustainability, Social Responsibility & Health Equity
9:00 am Panel Discussion: Putting the Spotlight on Social Responsibility & Health Equity Strategy in Pharmaceutical Organizations
Synopsis
- Communicating the business value of health equity and patient access strategies to secure buy
- How do you capture results and progress made in your heath equity strategy? How do you report on this?
- How do you support your Medical / R&D colleagues in delivering health equity programs? Especially to support the communities where you operate?
- How can we continue the momentum in corporate responsibility in the face of backlash in the US?
9:50 am Prestentation:Operationalizing the Intersection of Sustainability & Health Equity Strategy for Strategic Business Impact in Pharmaceutical Organizations
Synopsis
- Importance of integrating sustainability into business strategy, including target setting, operational model and governance for buy-in
- Operationalizing your social impact and health equity strategy; embedding the social impact lens into decision making across your organization to create long term and more sustainable changes in how companies operate
- The methodology and measurement frameworks behind a Novartis’ systematic approach to embedding social impact throughout the business
10:20 am Networking Break
TRACK 1
Environmental Sustainability
Environmental Sustainability
Practical Implementation of Environmental Sustainability & Net Zero Strategies
10:50 am Presentation: Creating the Road Map for Developing Net-Zero Sites in Biopharma Organizations
Synopsis
- Getting the buy in and becoming an industry leader in the development of net zero sites
- How to effectively collaborate with design build partners and then across the ecosystem
- From capturing the data, regulatory approval and certifications, uncover a biotech’s roadmap to green building and the following environmental and strategic benefits
11:20 am Presentation:Leveraging a Renewable Energy Strategy, Reducing Fleet and Manufacturing Emissions & Other Strategies to Execute Towards Carbon Neutral Goals
Synopsis
- Reducing fleet and manufacturing emissions, investing in renewable energy and removals/offsets, and managing data collection to show progress against internal goals
- Balancing progression in implementing environmental reduction strategies while keeping future technology in mind
- Uncover how Zoetis is progressing toward its carbon neutral goal
TRACK 2
ESG Strategy
ESG Strategy
Transforming Your Social Impact
10:50 am Presentation: Transforming Your Social impact: Identifying the Key Topics & Developing an Effective Social Strategy in Pharma Organizations
Synopsis
- How to get buy in and communicate the value of a social impact strategy
- How to identify the key areas for your social strategy including the underpinning governance
- How CSL Behring is effectively identifying the focus areas and the material topics in the social space as part of wider ESG strategy
11:20 am Presentation: Navigating the Complexities of Professionalising Philanthropy & Corporate Social Responsibility in Large Pharma
Synopsis
- How large pharma can support the communities with the least access to social determinants of health
- Securing buy into your corporate social responsibility agenda in life science organizations to improve corporate reputation
- Uncover how Novo Nordisk have transformed their social impact and subsequently how it has improved not just the health of specific populations but company culture too
11:50 am Lunch
Leveraging LCAs & Driving Sustainable Product Development in Life Sciences Organizations
1:00 pm Roundtable Workshop: How to Choose the Suitable Tools, Consultants & External Help As Your ESG & Sustainability Set Up Matures
Synopsis
Join this interactive discussion session moderated by an expert to uncover lessons learned, best practices and seek inspiration amongst peers at your table.
1:30 pm Presentation: Understanding the Future of Product and Pipeline: Enhancing Sustainable Product Development in Pharmaceutical Organizations
Synopsis
- Leveraging green chemistry and updated technology: including AI to reduce environmental impact and benefit the business by improving operational costs (i.e. water and waste)
- Lessons learned from executing an LCA pilot program in a leading pharma organization and developing a framework to map the total ESG values for new product development (developing an API or using reagents) to uncover
- How AbbVie are leveraging green chemistry and eco-design to inform sustainable product development while adhering to an evolving ESG regulatory framework
Establishing & Advancing Robust Organizational Governance
1:00 pm Presentation: Creating a Robust Governance Framework in Life Sciences Organizations
Synopsis
- Ensuring robust governance of ESG and sustainability practices including keeping accountability of progress to goals
- Other governance issues relating to the board: what does board oversight and accountability look like?
- How Smith + Nephew created a robust governance framework and are aligning to both UK and USA governance
1:30 pm Presentation: Building Dynamic ESG Governance at Speed in Biopharmaceutical Organizations to Address an Evolving Regulatory Landscape & Meet Stakeholder Needs
Synopsis
- Uncover how Jazz Pharmaceuticals have setup a robust and dynamic ESG governance structure at speed to make meaningful sustainability progress in two years.
- Outline practices and tips for applying principles and leveraging lessons learned from ‘mature’ organizations to curate an accelerated ESG strategy and operating model.
- Share specific successes, challenges and lessons learned and outlook for Jazz’s ESG strategy execution and preparation for next two years.